BACKGROUND: Many countries have initiated legislation to detect individuals who are unfit to drive, without any evidence that positive effects of these screening procedures outweigh negative effects.
OBJECTIVE:
To measure the potential effectiveness of a screening program to detect individuals unfit to drive.
DESIGN:
Markov decision analysis was used to compare no screening to two potential screening strategies.
PARTICIPANTS: Hypothetical cohorts of 10,000 45-year-old, 65-year-old, 75-year-old and 85-year-old individuals seen in primary care practices.
INTERVENTIONS:
Within the screening strategies: a clinical test without on-road confirmatory testing; a clinical test with on-road confirmatory testing, and an imposed driving cessation for patients with a positive test.
MEASUREMENTS:
For each strategy, we compared for two conditions (sleep disorders and dementia) the numbers of crash-related consequences prevented and of adverse events induced (primary objective) and measured the gain in quality-adjusted life years (secondary objective).
RESULTS:
For sleep disorders, on-road confirmatory annual testing was the preferred strategy. Whatever the medical condition and age when screening starts, no screening was always better than single-test screening without an on-road confirmatory testing. In sensitivity analyses, these baseline conclusions were only affected by extreme values of test specificity.
CONCLUSION:
Because of the expected difficult application and cost of road tests and annual screening by clinicians, the most acceptable strategy from public health, clinical, and individual points of view is likely to be no screening.
patients vary dramatically between states or provinces within a same country [2] [3] [4] . Introduction of similar policies is also debated in Europe 5 . Countries such as the United States, Australia or Canada have implemented procedures to assess fitness to drive, notably at periodical license renewal. [2] [3] [4] Whereas renewals of licenses are often simple administrative procedures, in other places applicants must perform tests such as vision or road tests when specific medical conditions are present [2] [3] [4] . Individuals who fail the tests may have their driving privileges revoked or restricted.
As driving is an essential component of modern life, and driving restrictions might have unwanted harmful consequences [5] [6] [7] , detection of drivers unfit to drive has become a debated issue 8 . Of major importance is the definition of the best opportunity to assess the ability to drive and whether physicians would participate on a voluntary or mandatory basis 8 . Although the usefulness of such programs should be judged by balancing potential positive and negative effect, there is, to our knowledge, no evidence to justify an implication of physicians in such a process.
We designed a decision analysis to compare the effectiveness of three possible strategies to deal with individuals potentially unfit to drive. We applied the decision analysis to sleep disorders and dementia, frequent conditions associated with an increased risk of collision 9 .
METHODS
A Markov decision model 10 was constructed to examine benefits and risks of implementing a program for detecting individuals who are unfit to drive, and analyzed using TREEAGE PRO 2007 (TreeAge Software Inc, Williamstown, MA, USA). Three strategies were evaluated from an individual driver's perspective and were applied to two conditions: sleep disorders and dementia: 1) no screening, 2) systematic screening by the primary care physician (single test), and 3) systematic screening with a confirmatory on-road test.
Model and Assumptions
Three subtrees were used to model events associated with the strategies (Fig. 1) . The probability of each event was based on published literature or assumed, when data were lacking. All relevant probabilities in the Markov cycle were adjusted according to a rhythm of screening set as annual testing or testing every three years. The single-test strategy was defined as testing all individuals not known to have the medical condition, whether they were truly without medical condition, or false negative at previous tests. Data on test sensitivity and specificity was extracted from literature on: the Epworth Sleepiness Scale 11 , the Multivariate Apnea Prediction (MAP) equation 12 or a twostage approach 13 for sleep disorders; the Mini Mental State Examination (MMSE) 14, 15 or a combination of tests 16 for dementia. For the two-test strategy, drivers with a positive first test were referred to on-road confirmatory testing, considered as a gold standard in the literature 6, 7 .
Potential side-effects of an early intervention imposed on all patients with true and false positive tests were considered. Once a patient was positive, there was no return to testing. For patients with true or false negative tests, we considered potential self-regulation strategies and their potential negative consequences. The no-screening strategy corresponds to the natural history of being a driver with or without the medical condition. The number of states in the Markov process was eight for the two screening strategies, and five for no screening.
The following were the baseline assumptions: 1) As done in published decision analyses 15, 16 , all individuals began with full driving privileges as "drivers without medical condition".
2) The medical condition was irreversible. 3) Compliance with the intervention, defined as a complete cessation of driving, was perfect. 4) Self-regulation strategies adopted by patients with the medical condition were also defined as a complete cessation of driving. 5) In the absence of data on self-regulation strategies adopted by drivers with a medical condition 17 , a driver without a medical condition would not adopt selfregulation strategies. 6) Side-effects of driving cessation (whether related to self-regulation or imposed) were defined as a loss of autonomy and its consequences. 7) Negative consequences of a crash for individuals submitted to screening (excluding other road users) were defined as a severe injury (person hospitalized at least during 24 hours, a standard definition in European countries 18 ). 8) To take into account long-term morbidity, drivers entering "severely injured" or "loss of autonomy" states (whether related to self-regulation or imposed driving cessation) could die from injury or consequences of the loss of autonomy, or remain in these states. To model morbidity related to the loss of autonomy (such as institutionalization for dementia, or related to depression for drivers aged 45 years old), we increased the risk of death in these states. 9) Because published data were lacking, the probability of side effects from the cessation of driving was set conservatively equal to the probability of crash-related con- sequences. 10) For sleep disorders, all probabilities except mortality were constant over time; for dementia, prevalence and incidence were varied with time. Data used in analyses are reported in Table 1 .
Outcomes
The main objective was to estimate and compare the number of severe injuries and related deaths that would be prevented (advantages), and the number of losses of autonomy and related deaths that would be induced (risks). We tracked variables into the Markov processes to count events (severe injury and related death as "crash-related consequences", and loss of autonomy and related death as "adverse events") with an individual Monte Carlo simulation. The numbers of expected events were estimated per 1,000 drivers seen in a primary care practice and simulated over a period of five years.
In a secondary objective, we assigned utilities to all states, estimated from a driver's perspective (appendix and Table 2) , and calculated quality-adjusted life years (QALYs) using Markov cohort analyses. For sleep disorders, a hypothetical cohort of 10,000 45-year-old individuals seen in primary care practices was simulated over five and 10 years. For dementia, age of entry in the cohort was 65 years of age, 75 years of age or 85 years of age .
Sensitivity Analyses
One-way and probabilistic Monte Carlo sensitivity analyses were performed to assess whether variables could affect the choice of the strategy. For one-way sensitivity analysis, variables varied discretely across intervals defined in Table 1 . To take into account uncertainty regarding the nature of the intervention (limited rather than full driving restrictions), the level of compliance, the frequency of self-regulation strategies, the probability of side-effects and the performance of tests, we run 10,000 Monte Carlo simulations with random selection of values from uniform distributions 31 , according to ranges defined in Table 1 , except for test specificity which varied up to one.
RESULTS

Baseline Analyses
The number of crash-related consequences was always smaller in single-test screening than in other strategies, both for annual testing and testing every three years (Table 3 ), but this option was associated with more adverse events. For dementia, whatever the age when annual screening started, the number of induced adverse events would always exceed that of crashrelated consequences prevented. Screening 1,000 85-year-old drivers seen in primary care practices every three years for dementia would prevent 586 crash-related consequences against 333 adverse events induced. Compared to no screening, a confirmatory on-road testing every three years would prevent 569 crash-related consequences against 270 adverse events induced, making this strategy the preferred option in that group. On-road confirmatory annual testing was also the preferred option for sleep disorders, with a number of crashrelated consequences prevented exceeding that of induced adverse events (10 against four per 1,000 drivers). Whatever the medical condition, the rhythm of testing, and age when screening starts, no screening was always better, in terms of QALYs, than single-test screening (Table 4 ). The loss in QALYs was five years for annual testing of sleep disorders. Single-test screening was preferred to no screening for dementia, only in the group of 85-year-old drivers tested every three years, with a five-month gain in QALYs. Adding a confirmatory on-road test (annual testing) was always preferred to no screening for sleep disorders, with a gain in QALYs ranging from two (at five years) to eight months (at 10 years). In the group of 85-year-old individuals tested every three years for dementia, adding a confirmatory on-road test was preferred to the single-test strategy, with a gain in QALYs always lower than one month.
Sensitivity Analyses
For sleep disorders, on-road testing every three years became the preferred strategy for a specificity of at least 73% and a crash rate for drivers without medical condition twice the baseline estimate (Table 5 ). The baseline conclusion to prefer no screening to single-test screening was mainly affected by the specificity of the tests, but threshold values were most often larger than the maximum possible value (Table 1) . Onroad testing in 65-year-old or 75-year-old drivers never became the preferred option. Baseline decisions were never affected in the group of 85-year-old individuals tested for dementia.
For sleep disorders, the baseline decision was affected in 62% of the simulations (Table 6 ). On-road confirmatory testing (every three years) became the preferred strategy for a specificity of at least 77% (included in the literature range) and a crash rate for drivers without medical condition almost twice the baseline estimate. For dementia (65-year-old and 75-year-old), the percentage of changing no screening to single-test screening (every 3 years) ranged from 6% to 30% with an associated specificity of 98%, larger than the maximum value of 95% reported in the literature.
DISCUSSION
For sleep disorders, annual on-road confirmatory testing of drivers 45 years and older seen in primary care practices was the preferred strategy. Whatever the medical condition and age when screening would start, no screening was better than single-test screening, except for dementia in the group of 85-year-old individuals. In sensitivity analyses, these baseline conclusions were mainly affected by extreme thus unlikely values of test specificity.
The use of a Markov model, efficient to model events recurrent over time 32 , was useful to model the recurrence of testing, or the possible recurrence of being involved in a crash. Moreover, our model can easily be generalized to other age groups, strategies, interventions and medical conditions other than sleep disorders and dementia. This is in contrast with the literature where most studies are focused on strategies limited at older drivers with cognitive impairment 15, 16, 33 .
Input parameters were often inaccurately described or lacking in the literature, especially for utilities used in our secondary objective. Utilities should not only represent quality of life but also its relationship with being able to drive or not. Utilities estimated in a sample of patients with the condition or in their relatives would have better face validity. Consistency of our conclusions, however, was tested by sensitivity analyses dealing with the uncertainty of probabilities and utilities, described as plausible distributions rather than discrete values 31 .
Our model took into account adverse events of imposed driving cessation, already mentioned in previous cost-benefit analyses of screening older drivers, but never analyzed 15, 16 .
Nevertheless, we lacked data on this parameter and assumed that the probability of adverse events would equal that of severe injury. In sensitivity analyses, conclusions of the baseline analysis were not affected by this assumption. We also assumed that a negative consequence of driving cessation would result from a loss of autonomy. The relation between lack of autonomy and the prevalence of institutionalization in patients with dementia or cognitive impairment is well documented in the literature 34, 35 . In patients with other conditions, risks associated with driving cessation could be an increase of depressive symptoms or a decrease of out-of-home activity levels, as suggested by Marattoli et al. 25, 36 . For instance, a 45-year-old driver can be precipitated into depression or isolation because of losing his job, due to the imposed driving cessation. Our model is general enough so that such other consequences could be analyzed, provided adequate data are available.
We also tested robustness of decisions by varying parameters for which the uncertainty was the greatest. The most important parameter was test specificity, but the single-test screening strategy was preferred only for extremely high values. Indeed, minimizing the number of false positives is important, given that the risk of crash-related consequences (mostly an issue for true positive) is likely to be lower than the risk of potential adverse consequences (an issue for all positive drivers).
Beside driving cessation, proposed interventions can be license restrictions (limitations of geographic area, time of day, or type of road) 37 , educational programs 38 , or treatment of the medical conditions, for instance for patients with sleep disorders 39, 40 . Modeling a complete driving cessation is relevant as it is included in existing policies [2] [3] [4] , and there are major uncertainties regarding effectiveness of alternative interventions. Nevertheless, the effect of license restrictions was indirectly considered in sensitivity analyses, by having compliance being able to be less than 100%. Unlike published decision analyses 15,16 , we did not consider costs. We can hypothesize that overall costs might be high for single-test screening, as the loss of autonomy and morbidity induced by imposed driving cessation would imply new needs for managing these consequences, or that benefits of on-road confirmatory testing might be smaller than costs, as this test is time-consuming and expensive 5 . We also believe that it is too early to carry satisfactory economic evaluations. Indeed, as suggested for instance by Drummond et al 41 , economical analyses are not relevant in the absence of sufficient evidence regarding the effectiveness of compared interventions. Moreover, a full assessment of costs would imply to define each screening strategy more thoroughly, especially regarding what would be a full intervention (including referral modalities by the clinician, organization of alternative modes of transportation for drivers denied driving privileges, health care for complications of the loss of autonomy...). The feasibility of on-road testing for dementia has been questioned, especially for drivers aged 85 years and older 42 .
Because driving is an over-learned task, standard road tests with step-by-step instructions do not necessarily test the skills of experienced drivers, nor reveal common errors. While it may be difficult to incorporate challenging driving situations into on-road evaluations, a greater level of difficulty may be needed to obtain a valid assessment of competency, particularly in experienced drivers with cognitive impairment 42 . The only screening strategy that may be feasible and effective in real conditions would be the single-test screening strategy for dementia, targeted at drivers aged 85 years and older seen in a primary care practice. However, in the absence of valid diagnostic tools, there are multiple barriers to formal assessment of driving competences of drivers with dementia 43, 44 , primary care patients' acceptance about dementia screening is strongly related to the impact on patients' independence, which is particularly related to driving privileges. Nevertheless, a recent study indicated that a medical contact, associated with an increased risk of crash in a population of older drivers from Quebec, could represent an opportunity to detect drivers potentially at risk 45 . However, the acceptability and feasibility for the primary care physician to use a battery of tests to detect inability to drive in all patients of various ages are likely to be low. Targeting a more restricted population with an increased risk could be more acceptable and feasible. For instance, tests for sleep disorders could be applied to those with consistent complaints (inappropriate sleep). Another key issue is to define what would be the role of the physician in managing unwanted consequences induced by the program.
From the targeted population point of view, acceptability of the process is also of major importance: acceptability of being discriminated as member of the group targeted by the strategy, acceptability of tests, acceptability of being false positive, acceptability of imposed driving cessation, acceptability of related loss of autonomy and associated needs to use other modes of transportation... Obviously, potential negative consequences of the program would be even less acceptable for drivers wrongly diagnosed unfit to drive. Finally, acceptability of individuals would have a major impact on compliance to the imposed intervention and thus on the potential effectiveness of the screening strategy.
CONCLUSION
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